AscellaHealth Supports Skin Cancer Awareness Month, Optimizes Plan Member Drug Therapy on Day One to Improve Outcomes, Lower Costs
BERWYN, Pa.--(BUSINESS WIRE)--May 21, 2019--
In honor of May as Skin Cancer Awareness Month, AscellaHealth (Ascella), a national Pharmacy Benefit Management (PBM) serving commercial, Medicare and Medicaid segments, urges Americans to learn the facts: Despite being one of the most preventable forms of cancer, there are over five million cases of skin cancer diagnosed in the United States each year. Designed to mitigate the complexity and high cost of managing skin cancer, Ascella’s Clinical and Educational Programs educate members on their prescribed therapy, assisting with high deductible/co-insurance costs by utilizing financial assistance programs and partnering with physicians and pharmacist throughout the member’s course of treatment.
“Ascella enables health plans, employer groups and unions to improve outcomes and care coordination for members with skin cancer,” says Dea Belazi, president and CEO, AscellaHealth, says, “Our high-touch model includes clinical interventions, adherence counseling, psychosocial assessment, integrated nursing staff, refill reminders and delivery coordination as part of our innovative specialty pharmacy strategy.”
The annual cost of treating nonmelanoma skin cancer in the U.S. is estimated at $4.8 billion, while the average annual cost of treating melanoma is estimated at $3.3 billion. Ascella’s program is available on a standalone basis, or as part of a full-service pharmacy benefit management option that includes specialty drug management, formulary management services/rebates, competitive pricing and innovative discounting, drug utilization review, case management services/therapy management, clinical review/prior authorization, pharmacy and therapeutic management committee, flexible claims adjudication system, drug information and news reporting.
“Ascella also provides discounted pricing as part of the significant value we create, especially in specialty drug pricing,” Belazi adds. “This May we are striving to make a difference in the lives of plan members living with skin cancer by optimizing benefit plans in a way that helps reduce costs.”
AscellaHealth, a national PBM serving commercial, Medicare and Medicaid segments offers high quality prescription drug management services along with other customizable services, such as carved-out specialty pharmacy services and cost-savings discount programs through its unique and proprietary service that extends discounts on prescription medications to customers more than any other PBM in the industry. Visit www.ascellahealth.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190521005723/en/
201.641.1911 x 54
KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL OTHER HEALTH MANAGED CARE
Copyright Business Wire 2019.
PUB: 05/21/2019 11:46 AM/DISC: 05/21/2019 11:46 AM